RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $770,272 | -56.6% | 91,590 | -35.2% | 0.00% | – |
| Q2 2023 | $1,773,987 | +20.0% | 141,241 | +57.4% | 0.00% | – |
| Q1 2023 | $1,477,771 | +10817.3% | 89,725 | +9803.4% | 0.00% | – |
| Q4 2022 | $13,536 | -77.1% | 906 | -65.6% | 0.00% | – |
| Q3 2022 | $59,000 | +5.4% | 2,633 | -22.1% | 0.00% | – |
| Q2 2022 | $56,000 | -92.2% | 3,381 | -86.0% | 0.00% | – |
| Q1 2022 | $721,000 | -49.8% | 24,094 | -48.5% | 0.00% | – |
| Q4 2021 | $1,437,000 | -9.7% | 46,820 | -7.2% | 0.00% | – |
| Q3 2021 | $1,592,000 | +42.1% | 50,466 | +64.9% | 0.00% | – |
| Q2 2021 | $1,120,000 | +229.4% | 30,599 | +211.6% | 0.00% | – |
| Q1 2021 | $340,000 | -64.7% | 9,820 | -57.7% | 0.00% | – |
| Q4 2020 | $964,000 | -31.4% | 23,206 | -29.7% | 0.00% | – |
| Q3 2020 | $1,406,000 | – | 33,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |